HCPCS Q0238
Inj, tocilizumab-aazg, hospi
Last reviewed August 2026 · DataLily AI data team
Pilot Analysis
Get the complete HCPCS Q0238 analysis
Tell us where to send it. Our team will prepare an analysis of HCPCS Q0238 covering what payers reimburse across markets and where your rate may sit, and email it to you within 5-10 business days. Need it faster? Book a demo.
HCPCS Q0238 at a glance
- Code
- Q0238
- Code type
- CPT/HCPCS
- Short descriptor
- Inj, tocilizumab-aazg, hospi
- Category
- ASC Ancillary
- ASC eligibility
- ASC-eligible (ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is HCPCS code Q0238?
HCPCS Q0238 is a CPT/HCPCS procedure code for Inj, tocilizumab-aazg, hospi. Its official short descriptor is "Inj, tocilizumab-aazg, hospi". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS Q0238 eligible in an ambulatory surgery center (ASC)?
HCPCS Q0238 is an ancillary service that can be provided in the ASC setting when it supports a surgical procedure.
Where is HCPCS Q0238 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
Reference information about ASC eligibility and typical procedure setting. Codes, descriptors, and ASC-eligibility status change over time. This is a coding reference, not billing, coding, or legal advice. Always verify against current guidance and individual payer policy before scheduling or billing. CPT is a registered trademark of the American Medical Association. Read the DataLily AI data methodology.